Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2012
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
Shili Xu, Alexey N Butkevich, Roppei Yamada, et al.
European Journal of Medicinal Chemistry
|
November 5, 2016
Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction
Feng-Hua Zhang, Bikash Debnath, Zhong-Liang Xu, et al.
Bioorganic & Medicinal Chemistry
|
July 23, 2011
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups
Xing Fan, Feng-Hua Zhang, Rasha I Al-Safi, et al.
European Journal of Medicinal Chemistry
|
December 21, 2022
Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors
Jian Yao, Yudong Yin, Hong Han, et al.
Nature Communications
|
October 6, 2016
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
Kavya Ramkumar, Soma Samanta, Anahita Kyani, et al.
Journal of Medicinal Chemistry
|
October 27, 2012
Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties
Li-Fan Zeng, Yong Wang, Roza Kazemi, et al.
Journal of Medicinal Chemistry
|
September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy
Brandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
European Journal of Medicinal Chemistry
|
December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy
Brandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Journal of Medicinal Chemistry
|
February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells
Stephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2012
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment
Shili Xu, Alexey N Butkevich, Roppei Yamada, et al.
European Journal of Medicinal Chemistry
|
November 5, 2016
Discovery of novel 3-hydroxypicolinamides as selective inhibitors of HIV-1 integrase-LEDGF/p75 interaction
Feng-Hua Zhang, Bikash Debnath, Zhong-Liang Xu, et al.
Bioorganic & Medicinal Chemistry
|
July 23, 2011
Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: a scaffold hopping approach using salicylate and catechol groups
Xing Fan, Feng-Hua Zhang, Rasha I Al-Safi, et al.
European Journal of Medicinal Chemistry
|
December 21, 2022
Pyrazolone derivatives as potent and selective small-molecule SIRT5 inhibitors
Jian Yao, Yudong Yin, Hong Han, et al.
Nature Communications
|
October 6, 2016
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
Kavya Ramkumar, Soma Samanta, Anahita Kyani, et al.
Journal of Medicinal Chemistry
|
October 27, 2012
Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties
Li-Fan Zeng, Yong Wang, Roza Kazemi, et al.
Journal of Medicinal Chemistry
|
September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy
Brandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
European Journal of Medicinal Chemistry
|
December 20, 2020
Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy
Brandt C Huddle, Edward Grimley, Mikhail Chtcherbinine, et al.
Journal of Medicinal Chemistry
|
February 24, 2011
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells
Stephanie M Stanford, Divya Krishnamurthy, Matthew D Falk, et al.
Page
of 4